Nanotop (Human Serum Albumin)

Human Serum Albumin, the active ingredient in Nanotop, is a plasma volume expander presented as a sterile solution for subcutaneous use. It increases plasma oncotic pressure, thereby expanding intravascular volume in patients with hypovolemia, shock or severe burns.

GNH USA supplies Nanotop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nanotop (Human Serum Albumin) is used as a plasma volume expander in conditions associated with low intravascular volume.

- Hypovolemia: restores circulating blood volume and improves tissue perfusion. - Hemorrhagic shock: supports hemodynamic stability during acute blood loss. - Severe burns: compensates for protein loss and fluid shifts to maintain circulatory volume.

Human Serum Albumin may cause a range of adverse reactions following subcutaneous administration.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or erythema: localized skin irritation. - Swelling: transient edema around the injection area. - Fever: low‑grade temperature elevation. - Hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Volume overload: excessive fluid accumulation leading to pulmonary edema. - Pulmonary edema: fluid accumulation in the lungs causing respiratory distress.

When using Nanotop, clinicians should observe several safety measures to minimize risk.

- Allergy assessment: verify no known hypersensitivity to human albumin. - Volume status: monitor patients for signs of fluid overload. - Renal function: evaluate kidney function before administration in patients with renal impairment. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant diuretics: adjust fluid management and monitor electrolyte balance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Human Serum Albumin can interact with other therapies that affect fluid balance or hemodynamics.

Major Interactions (Avoid): - High‑dose diuretics: may precipitate severe hypovolemia. - Calcium‑containing solutions: can cause precipitation and loss of product potency.

Moderate Interactions (Monitor Closely): - Blood pressure medications: monitor hemodynamic response and adjust doses as needed. - Renal replacement therapy: consider altered fluid removal and adjust albumin dosing. - Vasopressors: may require dose titration to maintain target blood pressure.